Skip to content

Pilot of Social Network Intrauterine Contraceptive (IUC) Intervention

The Woman-to-Woman Dissemination Project: Harnessing the Power of Social Networks to Increase IUC Use

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01965743
Enrollment
53
Registered
2013-10-18
Start date
2014-04-30
Completion date
2014-08-31
Last updated
2014-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attitudes

Keywords

intrauterine contraception (IUC), social networks, social influence, diffusion of innovation, intrauterine device (IUD), LARC

Brief summary

This study has two goals: 1) to test an approach to helping women who use intrauterine contraception (IUC) spread the word about this type of long-lasting, highly effective birth control method among their friends and family and; 2) to test ways of getting in touch with these women's friends and family so that we can track whether this approach is effective at spreading birth control information through social groups.

Detailed description

Pilot of peer IUC intervention We will assess its feasibility and acceptability as a low-cost intervention designed to be implemented at clinics providing family planning care. The intervention is being designed based off of phase 1 of this study, currently in the analysis phase, which included semi-structured interviews, focus groups, and surveys with a diverse sample of young women with varying degrees of experience with IUC. The intervention will consist of brief education about IUC and development of interpersonal skills, including how to initiate conversations about reproductive health issues in social settings and how to utilize social media. New IUC users will be recruited as dissemination agents to provide information about the option of IUC to their peers. Sixteen to twenty IUC users will be recruited from a local family planning clinic to receive the intervention, and we will conduct 3-month qualitative and quantitative follow-up of these individuals and their social contacts to assess the feasibility and impact of the intervention on IUC knowledge, attitudes and practices. We will also conduct a focus group with clinic staff about the feasibility of implementing the intervention in the clinical setting. Test of snowball sampling for social network analysis The social contacts will be recruited via one of two snowball sampling methods: active or passive recruitment. Eight to ten dissemination agents will be randomized into each recruitment arm. In the passive recruitment arm, the dissemination agents (IUC users receiving the intervention) will give referral cards to their social contacts, encouraging them to contact the research team. Dissemination agents will receive a small finder's fee for each friend who contacts the researchers. In the active recruitment approach, dissemination agents will ask their social contacts for permission to share their contact information with study staff, who will then actively reach out to the social contacts to ask if they would like to enroll in the study. Dissemination agents will also receive a finder's fee for each social contact who enrolls. In both recruitment arms, social contacts will complete a baseline survey and will be contacted for follow-up at 3 months to assess the effects of the intervention. We will also assess which recruitment method is most effective at enrolling members of the dissemination agents' social network. A randomly selected sub-set of participants will be selected to complete a more detailed qualitative interview at the end of the intervention. To minimize any potential Hawthorne effect, social contacts will initially be blinded as to the specific aims being assessed, and will be debriefed at the end of the study. This pilot study will provide the data necessary to prepare for a randomized controlled trial of this intervention.

Interventions

The intervention will consist of brief education about IUC and development of interpersonal skills, including how to initiate conversations about reproductive health issues in social settings and debunking common IUC myths

Sponsors

William and Flora Hewlett Foundation
CollaboratorOTHER
University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
15 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Dissemination agents: * Have an IUD placed for contraception at clinic visit or 2-6 weeks prior * speak English * be at least 15 years old * willing to disclose IUD use to friends and family * willing to have research staff contact their friends and family to participate in study related to family planning. * Social contacts: * Age 15-45 * speak English * able to get pregnant * ever sexually active with men * acquainted with dissemination agent. * Clinic staff: * Able to provide family planning care at clinic where intervention is being implemented.

Exclusion criteria

* Dissemination agents: * Using IUD for reason other than contraception * unwilling to disclose IUD use to any social contacts * unwilling to allow research staff to enroll friends and family in study as social contacts * do not speak or understand English. * Social contacts: * Unable to get pregnant * do not speak or understand English. * Clinic staff: * Not working at clinic at time of intervention.

Design outcomes

Primary

MeasureTime frameDescription
intrauterine contraception social network survey3 monthsSurvey of social network members about intrauterine contraception. At baseline and at 3 month follow-up, we will assess whether intervention recipients discussed intrauterine contraception with their social networks

Secondary

MeasureTime frameDescription
Perception of intrauterine contraception3 monthsSurvey of intrauterine contraception. At baseline and 3 month follow-up, we will assess social network members' attitudes towards IUC

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026